psoriasis

A ballpoint pen rests on top of a stack of documents ready for signing
Biotech

China biotech inks $135M deal for remaining rights to vTv med

Having secured regional rights to vTv’s inflammation drug, Newsoara is fronting $20 million to take ownership of the clinical-stage asset globally.
James Waldron Feb 2, 2026 10:10am
Graphic image of an arrow nailing the bullseye of a target

Alumis beams as pivotal data on Sotyktu rival drive stock surge

Jan 6, 2026 9:05am
Takeda

Takeda looks to 2026 FDA filing for Sotyktu rival zasocitinib

Dec 18, 2025 7:55am
crown royalty king queen win

J&J's IL-23 drug defeats Sotyktu in phase 3 psoriasis trial

Sep 17, 2025 9:45am
An arrow incrementally going up stairs before pointing straight up Blue background

Junshi sees ph. 3 psoriasis win for IL-17 drug, preps China push

Sep 8, 2025 4:54am
Shanghai China at sunrise

Fosun rises again, beaming up 3rd biotech deal in 3 weeks

Aug 29, 2025 10:05am